COMGEST GLOBAL INVESTORS S.A.S. - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 68 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q4 2018. The put-call ratio across all filers is 1.20 and the average weighting 0.6%.

Quarter-by-quarter ownership
COMGEST GLOBAL INVESTORS S.A.S. ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q3 2018$1,682,000
-93.1%
21,026
-91.4%
0.04%
-92.9%
Q2 2018$24,202,000
-53.1%
243,652
-61.8%
0.54%
-52.5%
Q1 2018$51,658,000
+3.2%
637,752
+0.3%
1.13%
+3.8%
Q4 2017$50,078,000
+52.3%
635,752
+78.5%
1.09%
+42.4%
Q3 2017$32,872,000356,2520.76%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q4 2018
NameSharesValueWeighting ↓
VERNIER CAPITAL PARTNERS, LP 137,557$11,142,0006.62%
COMGEST GLOBAL INVESTORS S.A.S. 637,752$51,658,0001.13%
Black Creek Investment Management Inc. 411,525$33,334,0001.09%
Hillhouse Capital Management 618,391$50,090,0000.88%
RUDMAN ERROL M 21,301$1,725,0000.83%
JUPITER ASSET MANAGEMENT LTD 263,705$21,360,0000.65%
York Capital Management Global Advisors, LLC 341,616$27,671,0000.62%
VONTOBEL ASSET MANAGEMENT INC 873,968$71,525,0000.51%
Temasek Holdings (Private) Ltd 990,000$80,190,0000.44%
WASATCH ADVISORS LP 292,216$23,669,0000.31%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders